
(MedPage Today) — Treatment with the gene therapy exagamglogene autotemcel (exa-cel; Casgevy) led to significant improvements in quality of life for patients with severe sickle cell disease or transfusion-dependent beta-thalassemia, data from…
Source link : https://www.medpagetoday.com/hematologyoncology/hematology/117181
Author :
Publish date : 2025-08-27 19:42:00
Copyright for syndicated content belongs to the linked
Source.